Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12267581 | 0.86 | MEN1 (0.43) | MEN1LMNAMAPTTHRBHTT | |
| SCHEMBL4966820 | 0.85 | MEN1 (0.43) | MEN1LMNAMAPTTHRBHTT | |
| SCHEMBL7750107 | 0.85 | MAPT (0.46) | MEN1LMNAMAPTTHRBHTT | |
| SCHEMBL1367336 | 0.85 | LMNA (0.61) | MEN1LMNAMAPTTHRBHTT | |
| SCHEMBL1656985 | 0.84 | MEN1 (0.42) | MEN1LMNAMAPTTHRBHTT | |
| Iodide SCHEMBL31142506 | 0.84 | HTT (0.45) | MEN1LMNAMAPTTHRBHTT | |
| Water SCHEMBL6796016 | 0.83 | LMNA (0.60) | MEN1LMNAMAPTTHRBHTT | |
| SCHEMBL10093777 | 0.83 | LMNA (0.46) | MEN1LMNAMAPTTHRBHTT | |
| SCHEMBL23628578 | 0.83 | TDP1 (0.41) | MEN1LMNAMAPTTHRBHTT | |
| Bromide SCHEMBL6537215 | 0.83 | MEN1 (0.41) | MEN1LMNAMAPTTHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9110069-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2015-08-18 | — | — | US | disclosed |
| EP-2129788-B1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS LLC (US) | 2014-09-03 | — | — | EP | disclosed |
| US-20140086844-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC (US) | 2014-03-27 | — | — | US | disclosed |
| US-8642014-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| US-8552027-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2013-10-08 | — | — | US | disclosed |
| US-20120035346-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2012-02-09 | — | — | US | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
| WO-2010083471-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC (US) | 2010-07-22 | — | — | WO | disclosed |
| EP-2129788-A2 | LUMINESCENT COMPOUNDS | Seta Biomedicals, LLC (US) | 2009-12-09 | — | — | EP | disclosed |
| US-7411068-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2008-08-12 | — | — | US | disclosed |
| WO-2008094637-A2 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS. LLC (US) | 2008-08-07 | — | — | WO | disclosed |
| US-20070281363-A1 | Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence | Terpetschnig, Ewald (US) | 2007-12-06 | — | — | US | disclosed |
| US-7250517-B2 | Luminescent compounds | Terpetschnig, Ewald A. (US) | 2007-07-31 | — | — | US | disclosed |
| US-20050202565-A1 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2005-09-15 | — | — | US | disclosed |
| US-20040166515-A1 | Luminescent compounds | TERPETSCHNIG, EWALD A. | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | MEN1 1430/4885LMNA 985/4885MAPT 4099/4885 |
| US-20140086844-A1 | LUMINESCENT COMPOUNDS | PHOSPHO1, PGLS, PFAS | MEN1 1189/4885LMNA 986/4885MAPT 1439/4885 |
| US-20120035346-A1 | LUMINESCENT COMPOUNDS | PHOSPHO1, PGLS, PFAS | MEN1 1504/4885LMNA 1037/4885MAPT 1265/4885 |
| US-20040166515-A1 | Luminescent compounds | RORC, NR2E3, RORB | MEN1 3748/4885LMNA 1196/4885MAPT 4542/4885 |
| US-20070281363-A1 | Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence | SPR, SRRT, SQLE | MEN1 2672/4885LMNA 1873/4885MAPT 3790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.